BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10351941)

  • 1. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.
    Tuder RM; Cool CD; Geraci MW; Wang J; Abman SH; Wright L; Badesch D; Voelkel NF
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1925-32. PubMed ID: 10351941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of PGI
    Ozen G; Amgoud Y; Abdelazeem H; Mani S; Benyahia C; Bouhadoun A; Tran-Dinh A; Castier Y; Guyard A; Longrois D; Silverstein AM; Norel X
    Prostaglandins Leukot Essent Fatty Acids; 2020 Sep; 160():102158. PubMed ID: 32673988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression of prostacyclin in lungs from patients with chronic obstructive pulmonary disease].
    Shen Q; Chen P; Yang M; Chen Y; Pen H; Xiang XD
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):114-7. PubMed ID: 20367951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.
    Humbert M; Monti G; Fartoukh M; Magnan A; Brenot F; Rain B; Capron F; Galanaud P; Duroux P; Simonneau G; Emilie D
    Eur Respir J; 1998 Mar; 11(3):554-9. PubMed ID: 9596101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
    Giaid A; Saleh D
    N Engl J Med; 1995 Jul; 333(4):214-21. PubMed ID: 7540722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of pulmonary hypertension treatments: Effect of 17β-estradiol on PGI
    Amgoud Y; Senbel A; Bouhadoun A; Abdelazeem H; Ozen G; Savané I; Manikpurage HD; Mani S; Tran-Dinh A; Castier Y; Guyard A; Longrois D; Silverstein AM; Norel X
    Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102321. PubMed ID: 34403986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic changes in explanted lungs after prostacyclin therapy for pulmonary hypertension.
    Achcar RO; Yung GL; Saffer H; Cool CD; Voelkel NF; Yi ES
    Eur J Med Res; 2006 May; 11(5):203-7. PubMed ID: 16723294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.
    Klein T; Klaus G; Kömhoff M
    Mediators Inflamm; 2015; 2015():654151. PubMed ID: 25684863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of prostacyclin/PGI2 synthase expression after cerebral ischemia-reperfusion.
    Fang YC; Wu JS; Chen JJ; Cheung WM; Tseng PH; Tam KB; Shyue SK; Chen JJ; Lin TN
    J Cereb Blood Flow Metab; 2006 Apr; 26(4):491-501. PubMed ID: 16094316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calpain 1 cleaves and inactivates prostacyclin synthase in mesenteric arteries from diabetic mice.
    Randriamboavonjy V; Kyselova A; Elgheznawy A; Zukunft S; Wittig I; Fleming I
    Basic Res Cardiol; 2017 Jan; 112(1):10. PubMed ID: 28013348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis.
    Spisni E; Griffoni C; Santi S; Riccio M; Marulli R; Bartolini G; Toni M; Ullrich V; Tomasi V
    Exp Cell Res; 2001 May; 266(1):31-43. PubMed ID: 11339822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered arterial expression patterns of inducible and endothelial nitric oxide synthase in pulmonary plexogenic arteriopathy caused by congenital heart disease.
    Berger RM; Geiger R; Hess J; Bogers AJ; Mooi WJ
    Am J Respir Crit Care Med; 2001 May; 163(6):1493-9. PubMed ID: 11371423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled prostacyclin following surgical repair of congenital heart disease--a pilot study.
    Carroll CL; Backer CL; Mavroudis C; Cook K; Goodman DM
    J Card Surg; 2005; 20(5):436-9. PubMed ID: 16153274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Lipoxygenase and 5-lipoxygenase activating protein (FLAP) immunoreactivity in lungs from patients with primary pulmonary hypertension.
    Wright L; Tuder RM; Wang J; Cool CD; Lepley RA; Voelkel NF
    Am J Respir Crit Care Med; 1998 Jan; 157(1):219-29. PubMed ID: 9445303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant Role for Regulatory T Cells in Protecting Females Against Pulmonary Hypertension.
    Tamosiuniene R; Manouvakhova O; Mesange P; Saito T; Qian J; Sanyal M; Lin YC; Nguyen LP; Luria A; Tu AB; Sante JM; Rabinovitch M; Fitzgerald DJ; Graham BB; Habtezion A; Voelkel NF; Aurelian L; Nicolls MR
    Circ Res; 2018 Jun; 122(12):1689-1702. PubMed ID: 29545367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in human newborns with congenital diaphragmatic hernia is associated with decreased vascular expression of nitric-oxide synthase.
    Shehata SM; Sharma HS; Mooi WJ; Tibboel D
    Cell Biochem Biophys; 2006; 44(1):147-55. PubMed ID: 16456243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension.
    Amano S; Tatsumi K; Tanabe N; Kasahara Y; Kurosu K; Takiguchi Y; Kasuya Y; Kimura S; Kuriyama T
    Respirology; 2004 Jun; 9(2):184-9. PubMed ID: 15182267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of the PGI2 producing enzyme system in the pathogenesis of pregnancy-induced hypertension].
    Seki H; Mitsuhashi N; Mizuno M; Satoh K
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1189-94. PubMed ID: 2120373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries.
    Liu B; Zhang Y; Zhu N; Li H; Luo W; Zhou Y
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1315-22. PubMed ID: 23986518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostacyclin (PGI2) synthase is a constitutively expressed enzyme in human endothelial cells.
    Spisni E; Bartolini G; Orlandi M; Belletti B; Santi S; Tomasi V
    Exp Cell Res; 1995 Aug; 219(2):507-13. PubMed ID: 7641804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.